1. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Issue 16 (2nd May 2014) Authors: Pappo, Alberto S.; Vassal, Gilles; Crowley, John J.; Bolejack, Vanessa; Hogendoorn, Pancras C. W.; Chugh, Rashmi; Ladanyi, Marc; Grippo, Joseph F.; Dall, Georgina; Staddon, Arthur P.; Chawla, Sant P.; Maki, Robert G.; Araujo, Dejka M.; Geoerger, Birgit; Ganjoo, Kristen; Marina, Neyssa; Blay, Jean... Journal: Cancer Issue: Volume 120:Issue 16(2014) Page Start: 2448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Issue 16 (2nd May 2014) Authors: Pappo, Alberto S.; Vassal, Gilles; Crowley, John J.; Bolejack, Vanessa; Hogendoorn, Pancras C. W.; Chugh, Rashmi; Ladanyi, Marc; Grippo, Joseph F.; Dall, Georgina; Staddon, Arthur P.; Chawla, Sant P.; Maki, Robert G.; Araujo, Dejka M.; Geoerger, Birgit; Ganjoo, Kristen; Marina, Neyssa; Blay, Jean... Journal: Cancer Issue: Volume 120:Issue 16(2014) Page Start: 2448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients. (March 2020) Authors: Pearson, Andrew D.J.; Rossig, Claudia; Lesa, Giovanni; Diede, Scott J.; Weiner, Susan; Anderson, John; Gray, Juliet; Geoerger, Birgit; Minard-Colin, Veronique; Marshall, Lynley V.; Smith, Malcolm; Sondel, Paul; Bajars, Marcis; Baldazzi, Claudia; Barry, Elly; Blackman, Sam; Blanc, Patricia; Capdev... Journal: European journal of cancer Issue: Volume 127(2020) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. (3rd August 2017) Authors: Moreno, Lucas; Caron, Hubert; Geoerger, Birgit; Eggert, Angelika; Schleiermacher, Gudrun; Brock, Penelope; Valteau-Couanet, Dominique; Chesler, Louis; Schulte, Johannes H; De Preter, Katleen; Molenaar, Jan; Schramm, Alexander; Eilers, Martin; Van Maerken, Tom; Johnsen, John Inge; Garrett, Michell... Journal: Expert opinion on drug discovery Issue: Volume 12:Number 8(2017:Aug.) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. (September 2020) Authors: Moreno, Lucas; Barone, Giuseppe; DuBois, Steven G.; Molenaar, Jan; Fischer, Matthias; Schulte, Johannes; Eggert, Angelika; Schleiermacher, Gudrun; Speleman, Frank; Chesler, Louis; Geoerger, Birgit; Hogarty, Michael D.; Irwin, Meredith S.; Bird, Nick; Blanchard, Guy B.; Buckland, Sean; Caron, Hube... Journal: European journal of cancer Issue: Volume 136(2020) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti-PD-1 shows promise against advanced paediatric Hodgkin lymphoma – Author's reply. Issue 3 (March 2020) Authors: Geoerger, Birgit Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: e127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissues. Issue 19 (13th June 2017) Authors: Majzner, Robbie G.; Simon, Jason S.; Grosso, Joseph F.; Martinez, Daniel; Pawel, Bruce R.; Santi, Mariarita; Merchant, Melinda S.; Geoerger, Birgit; Hezam, Imene; Marty, Virginie; Vielh, Phillippe; Daugaard, Mads; Sorensen, Poul H.; Mackall, Crystal L.; Maris, John M. Journal: Cancer Issue: Volume 123:Issue 19(2017) Page Start: 3807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study. Issue 1 (January 2020) Authors: Geoerger, Birgit; Zwaan, C Michel; Marshall, Lynley V; Michon, Jean; Bourdeaut, Franck; Casanova, Michela; Corradini, Nadège; Rossato, Gianluca; Farid-Kapadia, Mufiza; Shemesh, Colby S; Hutchinson, Katherine E; Donaldson, Francis; Liao, Minlei; Caron, Hubert; Trippett, Tanya Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bone Sarcomas: From Biology to Targeted Therapies. (27th November 2012) Authors: Gaspar, Nathalie; Di Giannatale, Angela; Geoerger, Birgit; Redini, Françoise; Corradini, Nadège; Enz-Werle, Natacha; Tirode, Franck; Marec-Berard, Perrine; Gentet, Jean-Claude; Laurence, Valérie; Piperno-Neumann, Sophie; Oberlin, Odile; Brugieres, Laurence Other Names: Pollock R. Academic Editor. Journal: Sarcoma Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Issue 12 (December 2021) Authors: Fischer, Matthias; Moreno, Lucas; Ziegler, David S; Marshall, Lynley V; Zwaan, C Michel; Irwin, Meredith S; Casanova, Michela; Sabado, Constantino; Wulff, Beate; Stegert, Mario; Wang, Luojun; Hurtado, Felipe K; Branle, Fabrice; Geoerger, Birgit; Schulte, Johannes H Journal: Lancet oncology Issue: Volume 22:Issue 12(2021) Page Start: 1764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗